Assessing the harms of polypharmacy requires careful interpretation and consistent definitions

Is polypharmacy always hazardous? A retrospective cohort analysis using linked electronic health records from primary and secondary care

(2014) Rupert A. Payne et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Polypharmacy and excessive polypharmacy in octogenarians and older acutely hospitalized patients

(2014) Christoph Strehblow et al.   WIENER KLINISCHE WOCHENSCHRIFT

The effect of physical multimorbidity, mental health conditions and socioeconomic deprivation on unplanned admissions to hospital: a retrospective cohort study

(2013) R. A. Payne et al.   CANADIAN MEDICAL ASSOCIATION JOURNAL

Polypharmacy Patterns: Unravelling Systematic Associations between Prescribed Medications

(2013) Amaia Calderón-Larrañaga et al.   PLoS One

High-Risk Prescribing and Incidence of Frailty Among Older Community-Dwelling Men

(2012) D Gnjidic et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Polypharmacy cutoff and outcomes: five or more medicines were used to identify community-dwelling older men at risk of different adverse outcomes

(2012) Danijela Gnjidic et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

Polypharmacy, length of hospital stay, and in-hospital mortality among elderly patients in internal medicine wards. The REPOSI study

(2011) Alessandro Nobili et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

The Effects of Polypharmacy in Older Adults

(2008) SN Hilmer et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS